Homozygous Familial Hypercholesterolemia: Role of NPs and PAs in Achieving Optimal Outcomes Using Novel Therapeutic Interventions

Article Type

Changed

Tue, 05/21/2019 - 12:16

Display Headline

Joyce L. Ross, CRNP, CCS, FPCNA, FNLA, Diplomate Accreditation Council for Clinical Lipidology

Click here to read the supplement.

Author and Disclosure Information

Joyce L. Ross, CRNP, CCS, FPCNA, FNLA, Diplomate Accreditation Council for Clinical Lipidology

Publications

Sections

Author and Disclosure Information

Joyce L. Ross, CRNP, CCS, FPCNA, FNLA, Diplomate Accreditation Council for Clinical Lipidology

Author and Disclosure Information

Joyce L. Ross, CRNP, CCS, FPCNA, FNLA, Diplomate Accreditation Council for Clinical Lipidology

Joyce L. Ross, CRNP, CCS, FPCNA, FNLA, Diplomate Accreditation Council for Clinical Lipidology

Click here to read the supplement.

Joyce L. Ross, CRNP, CCS, FPCNA, FNLA, Diplomate Accreditation Council for Clinical Lipidology

Click here to read the supplement.

Publications

Publications

Article Type

Display Headline

Homozygous Familial Hypercholesterolemia: Role of NPs and PAs in Achieving Optimal Outcomes Using Novel Therapeutic Interventions

Display Headline

Homozygous Familial Hypercholesterolemia: Role of NPs and PAs in Achieving Optimal Outcomes Using Novel Therapeutic Interventions

Sections

Disallow All Ads

Alternative CME

Teaser Media

User login